Guaifenesin, Pseudoephedrine

Non Drowsy Regular Strength Contac Cold Chest Congestion

200 MG + 30 MG CapsuleCanadaCancelledAuthorised 27 Oct 1998

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Respidina Expectorante Junior 6 MG/ML + 20 MG/ML Solucion OralSpain · 20 mg/ml + 6 mg/ml · solución oral · Laboratorios Cinfa S.A.Same substance
Iniston Mucosidad y Congestion 20 MG/ML + 6 MG/ML JarabeSpain · 30 mg + 100 mg · jarabe · Jntl Consumer Health (Spain) S.L.Same substance
GuafedrinSaudi Arabia · Riyadh PharmaSame substance
Robitussin-Pe SyrupSaudi Arabia · Fereva RichmondSame substance
Robitussin PS SyrupSingapore · 200 mg/10 ml + 60 mg/10 ml · syrup · Haleon Singapore Pte. LTD.Same substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Guaifenesin, Pseudoephedrine

Non Drowsy Regular Strength Contac Cold Chest Congestion

200 MG + 30 MG CapsuleCanadaCancelledAuthorised 27 Oct 1998

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Guaifenesin and Pseudoephedrine HydrochlorideUnited States · 1.2GM; 120MG, 600MG; 60MG · tablet, extended release · Granules

Mucinex DUnited States · 1.2GM; 120MG, 600MG; 60MG · tablet, extended release · RB HLTH

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Guaifenesin, Pseudoephedrine
Strength: 200 MG + 30 MG
Dosage form: Capsule
Route: Oral
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 27 Oct 1998
Registration: DIN 02237850
Marketing authorisation holder: Glaxosmithkline Consumer Healthcare Ulc
ATC code: R05CA10
Group: Respiratory system
Supply: NON-PRESCRIPTION DRUGS

Novahistex Expectorant with DecongestantGuaifenesin + Pseudoephedrine · 100 MG / 5 ML + 30 MG / 5 ML · LiquidCanadaCancelled

Triaminic Decongest+Expect Liqui-Gels CapGuaifenesin + Pseudoephedrine · 100 MG / CAP + 30 MG / CAP · CapsuleCanadaCancelled